PTCT- Ptc Therapeutics, Inc.

Name: Ptc Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Ptc Therapeutics, Inc. (PTCT) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 21 sells. PTCT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Klein Matthew B.	394.1K	$31.90M	-
VP	Boulding Mark Elliott	113.7K	$9.21M	-10,462
CFO	Gravier Pierre	90.3K	$7.31M	-
Other	Pauwels Eric	80.1K	$6.49M	-
VP	Golden Lee Scott	79.1K	$6.41M	-

Activity

Buys and sells only

Transactions

10 filings · page 13

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 24, 2023	Pauwels Eric62	Chief Business Officer	Sell	359	$47.45	$17,035.02	-0.5%	+11.8%	-42.4%
Jan 24, 2023	Hill Emily Luisa62	Chief Financial Officer	Sell	223	$47.45	$10,581.64	-0.5%	+11.8%	-42.4%
Jan 24, 2023	Almstead Neil Gregory52	Chief Technical Ops Officer	Sell	44	$47.45	$2,087.86	-1.3%	+11.8%	-42.4%
Jan 11, 2023	Almstead Neil Gregory52	Chief Technical Ops Officer	Sell	910	$43.58	$39,653.89	-0.7%	+6.1%	-37.1%
Jan 11, 2023	Peltz Stuart Walter57	Chief Executive Officer	Sell	3,480	$43.62	$151,804.77	-0.8%	+6.1%	-37.1%
Jan 11, 2023	Boulding Mark Elliott55	Exec. VP And CLO	Sell	1,085	$43.58	$47,288.41	-0.7%	+6.1%	-37.1%
Jan 11, 2023	Hill Emily Luisa62	Chief Financial Officer	Sell	915	$43.58	$39,879.96	-1.0%	+6.1%	-37.1%
Jan 11, 2023	Klein Matthew B.55	Chief Operating Officer	Sell	4,517	$43.64	$197,129.42	-2.8%	+6.1%	-37.1%
Jan 11, 2023	Pauwels Eric62	Chief Business Officer	Sell	1,234	$43.59	$53,793.84	-0.9%	+6.1%	-37.1%
Jan 11, 2023	Utter Christine Marie58	SVP, Finance &CAO	Sell	906	$43.59	$39,492.14	-1.2%	+6.1%	-37.1%

← PrevPage 13Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC